Avacincaptad pegol
Customize your policy alerts
Sign up for healthspring Policy OTH903.045 alerts
Get alerted when Policy OTH903.045 changes without checking for updates manually.
Monitor payer policy activity
Coverage review for avacincaptad pegol, subject to the member’s benefit plan, applicable state regulations, FDA-approved labeling, recognized clinical evidence, and an Ohio-specific exception for certain recognized off-label uses.
A new medical policy establishes medical-necessity criteria for avacincaptad pegol (Izervay) in adults with geographic atrophy secondary to age-related macular degeneration.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.